Treatment of canine atopic dermatitis with cetirizine a second generation antihistamine: A single-blinded, placebo-controlled study

Canadian Veterinary Journal

Volumn 45, Issue 5, 2004, Pages 414-417

  Cook, Christopher P ^a   Scott, Danny W ^a   Miller Jr , William H ^a   Kirker, J Edward ^a   Cobb, Shaun M ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALIMEMAZINE; ANTIHISTAMINIC AGENT; ASTEMIZOLE; BROMPHENIRAMINE; CETIRIZINE; CLEMASTINE; CYPROHEPTADINE; DOXEPIN; LORATADINE; PLACEBO; PREDNISONE; TERFENADINE; TRIPELENNAMINE;

ADOLESCENT; AGED; ARTICLE; ATOPIC DERMATITIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DOG; DOG DISEASE; FEMALE; MALE; NONHUMAN; OUTCOMES RESEARCH; PRURITUS; VOMITING;

ADMINISTRATION, ORAL; ANIMALS; CETIRIZINE; CROSS-OVER STUDIES; DERMATITIS, ATOPIC; DOG DISEASES; DOGS; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; MALE; PLACEBOS; PRURITUS; RANDOM ALLOCATION; SINGLE-BLIND METHOD; TREATMENT OUTCOME; VOMITING;

CANIS FAMILIARIS;

EID: 2942665534     PISSN: 00085286     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Scott DW, Miller WH Jr, Griffin CE. Muller & Kirk's Small Animal Dermatology VI. Philadelphia: WB Saunders, 2001:543-666.
2. Hillier A, Griffin CE. The ACVD task force on canine atopic dermatitis: Incidence and prevalence. Vet Immunol Immunopathol 2001;81:147-151.
3. Schwartz LB. Biology of mast cells in allergic inflammation. In: Middleton E, Reed CE, Ellis EF, eds. Allergy Principles and Practice V. St. Louis: CV Mosby, 1998:261-274.
4. Hill PB, Olivry T. The ACVD task force on canine atopic dermatitis V: Biology and role of inflammatory cells in cutaneous allergic reactions. Vet Immunol Immunopathol 2001;81:187-197.
5. Slater JW, Zechnich AD, Hasby DG. Second-generation antihistamines: A comparative review. Drugs 1999;57:31-47.
6. DeBoer DJ, Griffin CE. The ACVD task force on canine atopic dermatitis XXI: Antihistamine pharmacotherapy. Vet Immunol Immunopathol 2001;81:323-329.
7. Simons FE. Prevention of acute urticaria in young children with atopic dermatitis. J Allergy Clin Immunol 2001;107:703-706.
8. Zuberbier T, Henz BM. Use of cetirizine in dermatologic disorders. Ann Allergy Asthma Immunol 1999;83:476-480.
9. Purohit A, Duvernelle C, Melac M, et al. Twenty-four hours of activity of cetirizine and fexofenadine in the skin. Ann Allergy Asthma Immunol 2001;86:387-392.
10. Fadel R, Ramboer I, Chatterjee N, et al. Cetirizine inhibits bradykinin-induced cutaneous wheal and flare in atopic and healthy subjects. Allergy 2000;255:382-385.
11. Ballmer-Weber BK, Gex-Collect C, Wuthrich B. Inhibition of histamine or allergen-induced wheals by a single dose of acrivastine, fexofenadine, or cetirizine. J Invest Allerg Clin Immunol 1999;9:351-355.
12. Atkins PC, Zweiman B, Moskovitz A, et al. Cellular inflammatory responses and mediator release during early developing late-phase allergic cutaneous inflammatory responses: Effects of cetirizine. J Allergy Clin Immunol 1997;99:806-811.
13. Turner CR, Andresen CJ, Smith WB, et al. Characterization of a primate model of asthma using antiallergy/antiasthma agents. Inflamm Res 1996;45:239-245.
14. Jinquan T, Reimert CM, Deleuran B, et al. Cetirizine inhibits the in vitro and ex vivo chemotactic response of T-lymphocytes and monocytes. J Allergy Clin Immunol 1995;95:979-986.
15. Snyman JR, Sommers DK, van Wyk M, et al. Effect of long-term cetirizine treatment on the cutaneous hypersensitivity reaction in patients with grass pollen allergy. Eur J Clin Pharmacol 1994;46: 19-22.
16. De Vos C, Joseph M, Leprevost C, et al. Inhibition of human eosinophil chemotaxis and of the IgE-dependent stimulation of human blood platelets by cetirizine. Int Arch Allergy Immunol 1989;88:212-215.
17. Fasce PA, Ciprandi L, Pronzato G, et al. Cetirizine reduces ICAM-1 on epithelial cells during nasal minimal persistent inflammation in asymptomatic children with mite-allergic asthma. Int Arch Allergy Immunol 1996;109:272-276.
18. Weissenburger J, Noyer M, Cheymol G, et al. Electrophysical effects of cetirizine, astemizole, and D-sotalol in a canine model of long QT syndrome. Clin Exp Allergy 1999;29:190-196.
19. De Vos C, Maleux M, Baltes E, et al. Inhibition of histamine and allergen skin wheal by cetirizine in 4 animal species. Ann Allergy 1987;59:278-282.
20. Rees C. New drugs in veterinary dermatology. Vet Clin North Am Small Anim Pract 1999;29:1449-1460.
21. Medleau L, Hnilica K. Small Animal Dermatology: A Color Atlas and Therapeutic Guide. Philadelphia: WB Saunders, 2001:106.
22. Héripret D. Les antiprurigineux non stéroïdiens. Prat Méd Chir Anim Comp 1993;28:73-80.
23. Nesbitt GH, Ackerman LJ. Canine and Feline Dermatology. Diagnosis and Treatment. Trenton: Veterinary Learning Systems, 1998:98.
24. Scott DW, Miller WH Jr, Cayatte SM, et al. Failure of terfenadine as an antipruritic agent in atopic dogs: results of a double-blinded study. Can Vet J 1994;35:286-288.
25. Scott DW, Miller WH Jr, Decker GA, et al. Failure of cyproheptadine hydrochloride as an antipruritic agent in allergic dogs: Results of a double-blinded, placebo-controlled study. Cornell Vet 1992;82: 247-251.
26. Paradis M, Scott DW, Giroux D. Further investigations on the use of nonsteroidal and steroidal anti-inflammatory agents in the management of canine pruritus. J Am Anim Hosp Assoc 1991;27: 44-48.
27. Paradis M. Nonsteroidal antipruritic drugs in dogs and cats: An update. Bull Can Acad Vet Dermatol 1996;12:3-7.
28. Scott DW, Miller WH Jr. Antihistamines in the management of allergic pruritus in dogs and cats. J Small Anim Pract 1999;40: 359-364.
29. La Rosa M, Ranno C, Musarra I, et al. Double-blind study of cetirizine in atopic eczema in children. Ann Allergy 1994;73: 117-122.
30. 1-receptor antagonist cetirizine in very young children with atopic dermatitis. ETAC Study Group. Early treatment of the atopic child. J Allergy Clin Immunol 1999;104:433-440.
31. 1-antihistamines on histamine release from dispersed canine cutaneous mast cells. Am J Vet Res 1997;58:293-297.